Latest News

Tale of Numbers – Year 2022 of China Medical System(867.HK)
2022-12-31

Tale of Numbers – Year 2022 of China Medical System(867.HK)

Learn More
China Medical System (867.HK) won the Awards of “Listed Biopharma with the Most Growing Value” and “Overseas Listed Company with the Most Growing Value”.
2022-12-30

China Medical System (867.HK) won the Awards of “Listed Biopharma with the Most Growing Value” and “Overseas Listed Company with the Most Growing Value”.

On December 28, the rank of “the 12th China’s Top Listed Companies by popularity 2022” was grandly released. China Medical System Holdings Limited (“CMS” or the “Group”) won both the awards of “Listed Biopharma with the Most Growing Value” and “Overseas Listed Company with the Most Growing Value”. The rank of Top Listed Companies by popularity was held by The National Business Daily, aiming to build reputation and create value for the capital market. This year the selection went through four stages, these are public nomination, big data screening, model screening, and institution + public voting. After more than 3 months of selection, nearly 3,000 listed companies were nominated, and 15 major awards were finally released. Winning both awards reflects the comprehensive strength of CMS in the bio-pharmaceutical industry and demonstrates high affirmation from capital market on its quality development. In recent years, CMS has driven its development through innovation, continuously strengthened the open platform, and joined hands with global biotechnology innovation companies to develop differentiated innovative products to meet […]

Learn More
<strong>China Medical System(867.HK) Won “Best Information Disclosure Award” in China IR Annual Awards</strong>
2022-12-23

China Medical System(867.HK) Won “Best Information Disclosure Award” in China IR Annual Awards

December 22, 2022, the 6th China IR Annual Awards was grandly held, and China Medical System Holdings Limited (CMS) was awarded “Best Information Disclosure Award”! China IR Annual Awards aims to honor outstanding IR teams and individuals of listed companies that have made contributions to promoting industry reformation and development. The selection covers more than 600 companies listed in Mainland, Hong Kong and US stock markets. China IR Annual Awards is reported by more than 30 mainstream financial media with tens of millions hits on the internet, and it has become one of the most influential selections in the IR field of listed companies in China. CMS always attaches great importance to transparent, timely and effective communication with investors. Based on its high standard corporate governance, CMS constantly improves its information disclosure system and quality, and enriches information disclosure channels. On the basis of ensuring mandatory information disclosure in accordance […]

Learn More

All News